Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques

Biochemical Journal

Volumn 370, Issue 2, 2003, Pages 729-735

  Woods, Alan A ^a   Linton, Stuart M ^a   Davies, Michael J ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

Author keywords

Atherosclerosis; Chloramine; Extracellular matrix; Hypochlorite; Myeloperoxidase; Protein oxidation

Indexed keywords

CATALYSIS; CHLORINATION; OXIDATION; TRANSITION METALS;

ATHEROSCLEROSIS;

ENZYMES;

2 HYDROXYPHENYLALANINE; AMINO ACID; CHLORAMINE DERIVATIVE; CHLORIDE; DOPA; HAEM ENZYME MYELOPEROXIDASE; META TYROSINE; MYELOPEROXIDASE; OXYGEN RADICAL; PHENYLALANINE; PROTEIN; UNCLASSIFIED DRUG;

ARTERY; ARTERY LESION; ARTICLE; ATHEROSCLEROTIC PLAQUE; COMPARATIVE STUDY; CONTROLLED STUDY; DECOMPOSITION; EXTRACELLULAR MATRIX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; TISSUE;

AMINO ACIDS; ANIMALS; AORTA; ARTERIOSCLEROSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXTRACELLULAR MATRIX; HUMANS; HYPOCHLOROUS ACID; OXIDATION-REDUCTION; SWINE;

SUS SCROFA;

EID: 0037336908     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20021710     Document Type: Article

References (59)

1. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C. and Witztum, J. L. (1989) Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320, 915-924
2. Heinecke, J. W. (1998) Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 141, 1-15
3. Dean, R. T. and Kelly, D. T. (eds) (2000) Atherosclerosis: Gene Expression, Cell Interactions and Oxidation, pp. 1-450, Oxford University Press, Oxford
4. Suarna, C., Dean, R. T., May, J. and Stocker, R. (1995) Human atherosclerotic p aque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler. Thromb. Vasc. Biol. 15, 1616-1624
5. Goldstein, J. L., Basu, S. K. and Brown, M. S. (1983) Receptor mediated endocytosis of low density lipoprotein in cultured cells. Methods Enzymol. 98, 241-260
6. Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L. and Steinberg, D. (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. U.S.A. 81, 3883-3887
7. Steinbrecher, U. P., Zhang, H. and Lougheed, M. (1990) Role of oxidatively modified LDL in atherosclerosis. Free Radic. Biol. Med. 9, 155-168
8. Jessup, W., Dean, R. T., de Whalley, V. C., Rankin, S. M. and Leake, D. S. (1990) The role of oxidative modification and antioxidants in LDL metabolism and atherosclerosis. Adv. Exp. Med. Biol. 264, 139-142
9. Parhami, F., Fang, Z. T., Fogelman, A. M., Andalibi, A., Territo, M. C. and Berliner, J. A. (1993) Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J. Clin. Invest. 92, 471-478
10. Rajavashisth, T. B., Yamada, H. and Mishra, N. K. (1995) Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL. Involvement of nuclear factor-κB. Arterioscl. Thromb. Vasc. Biol. 15, 1591-1598
11. Bolton, E. J., Jessup, W., Stanley, K. K. and Dean, R. T. (1994) Enhanced LDL oxidation by murine macrophage foam cells and their failure to secrete nitric oxide. Atherosclerosis 106, 213-223
12. Kramsch, D. M., Franzblau, C. and Hollander, W. (1974) Components of the protein-lipid complex of arterial elastin: their role in the retention of lipid in atherosclerotic lesions. Adv. Exp. Med. Biol. 43, 193-210
13. Robert, L., Jacob, M. P., Frances, C., Godeau, G. and Hornebeck, W. (1984) Interaction between elastin and elastases and its role in the aging of the arterial wall, skin and other connective tissues. A review. Mech. Ageing Dev. 28, 155-166
14. Robert, L., Robert, A. M. and Jacotot, B. (1998) Elastin-elastase-atherosclerosis revisited. Atherosclerosis 140, 281-295
15. Kramsch, D. M. and Hollander, W. (1973) The interaction of serum and arterial lipoproteins with elastin of the arterial intima and its role in the lipid accumulation in atherosclerotic plaques. J. Clin. Invest. 52, 236-247
16. Wagner, W. D., Salisbury, B. G. J. and Rowe, H. A. (1987) A proposed structure of chondroitin 6-sulfate proteoglycan of human normal and adiacent atherosclerotic plaque. Arteriosclerosis 6, 407-417
17. Rucker, R. B. and Tinker, D. (1977) Structure and metabolism of arterial elastin. Int. Rev. Exp. Pathol. 17, 1-47
18. LaBella, F. S. (1974) Arterial mesenchyme and arteriosclerosis. Enzymic vs non-enzymic factors in the deterioration of connective tissue. Adv. Exp. Med. Biol. 43, 377-402
19. Vissers, M. C. M. and Winterbourn, C. C. (1991) Oxidative damage to fibronectin. 1. The effects of the neutrophil myeloperoxidase system and HOCl. Arch. Biochem. Biophys. 285, 53-59
20. Underwood, P. A., Bean, P. A. and Whitelock, J. M. (1998) Inhibition of endothelial cell adhesion and proliferation by extracellular matrix from vascular smooth muscle cells: role of type V collagen. Atherosclerosis 141, 141-152
21. Underwood, P. A., Mitchell, S. M. and Whitelock, J. M. (1998) Heparin fails to inhibit the proliferation of human vascular smooth muscle cells in the presence of human serum. J. Vasc. Res. 35, 449-460
22. Hazen, S. L. and Heinecke, J. W. (1997) 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalysed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99, 2075-2081
23. Fu, S., Davies, M. J., Stocker, R. and Dean, R. T. (1998) Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem. J. 333, 519-525
24. Upston, J. M., Niu, X., Brown, A. J., Mashima, R., Wang, H., Senthilmohan, R., Kettle, A. J., Dean, R. T. and Stocker, R. (2002) Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Am. J. Pathol. 160, 701-710
25. Fu, S., Dean, R. T., Davies, M. J. and Heinecke, J. W. (2000) in Atherosclerosis: Gene Expression, Cell Interactions and Oxidation (Dean, R. T. and Kelly, D., eds.), pp. 301-325, Oxford University Press, Oxford
26. Heinecke, J. W., Li, W., Daehnke, H. L. and Goldstein, J. A. (1993) Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J. Biol. Chem. 268, 4069-4077
27. Kettle, A. J. (1996) Neutrophils convert tyrosyl residues in albumin to chlorotyrosine. FEBS Lett. 379, 103-106
28. Davies, M. J., Fu, S., Wang, H. and Dean, R. T. (1999) Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radic. Biol. Med. 27, 1151-1163
29. Kettle, A. J. and Winterbourn, C. C. (1997) Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Rep. 3, 3-15
30. Daugherty, A., Dunn, J. L., Rateri, D. L. and Heinecke, J. W. (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94, 437-444
31. Kutter, D., Devaquet, P., Vanderstocken, G., Paulus, J. M., Marchal, V. and Gothot, A. (2000) Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit? Acta Haematol. 104, 10-15
32. Nikpoor, B., Turecki, G., Fournier, C., Theroux, P. and Rouleau, G. A. (2001) A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am. Heart. J. 142, 336-369
33. Zhang, R., Brennan, M. L., Fu, X., Aviles, R. J., Pearce, G. L., Penn, M. S., Topol, E. J., Sprecher, D. L. and Hazen, S. L. (2001) Association between myeloperoxidase levels and risk of coronary artery disease. J. Am. Med. Assoc. 286, 2136-2142
34. McGowan, S. E. (1990) Mechanisms of extracellular matrix proteoglycan degradation by human neutrophils. Am. J. Respir. Cell. Mol. Biol. 2, 271-279
35. Carr, A. C., Myzak, M. C., Stocker, R., McCall, M. R. and Frei, B. (2000) Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis. FEBS Lett. 487, 176-180
36. Upritchard, J. E. and Sutherland, W. H. (1999) Oxidation of heparin-treated low density lipoprotein by peroxidases. Atherosclerosis 146, 211-219
37. Stadtman, E. R. (1993) Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu. Rev. Biochem. 62, 797-821
38. Daphna, E. M., Michaela, S., Eynat, P., Irit, A. and Rimon, S. (1998) Association of myeloperoxidase with heparin: oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme Mol. Cell. Biochem. 183, 55-61
39. Hazell, L. J., Arnold, L., Flowers, D., Waeg, G., Malle, E. and Stocker, R. (1996) Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97, 1535-1544
40. Hazell, L. J., Baernthaler, G. and Stocker, R. (2001) Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis. Free Radic. Biol. Med. 31, 1254-1262
41. Linton, S., Davies, M. J. and Dean, R. T. (2001) Protein oxidation in ageing. Exp. Gerentol. 36, 1503-1518
42. Hawkins, C. L. and Davies, M. J. (1999) Hypochlorite-induced oxidation of proteins in plasma: formation of chloramines and nitrogen-centred radicals and their role in protein fragmentation. Biochem. J. 340, 539-548
43. Hawkins, C. L. and Davies, M. J. (1998) Hypochlorite-induced damage to proteins: formation of nitrogen-centred radicals from lysine residues and their role in protein fragmentation. Biochem. J. 332, 617-625
44. Hawkins, C. L., Rees, M. D. and Davies, M. J. (2002) Superoxide radicals can act synergistically with hypochlorite to induce damage to proteins. FEBS Lett. 510, 41-44
45. Blumencrantz, N. and Asboe-Hansen, G. (1973) New method for quantitative determination of uronic acids. Anal. Biochem. 54, 484-489
46. Fu, S. L. and Dean, R. T. (1997) Structural characterization of the products of hydroxyl-radical damage to leucine and their detection on proteins. Biochem. J. 324, 41-48
47. Fu, S., Hick, L. A., Sheil, M. M. and Dean, R. T. (1995) Structural identification of valine hydroperoxides and hydroxides on radical-damaged amino acid, peptide, and protein molecules. Free Radic. Biol. Med. 19, 281-292
48. Dean, R. T., Fu, S., Gieseg, S. and Armstrong, S. G. (1996) in Free Radicals: a Practical Approach (Punchard, N. and Kelly, F. J., eds.), pp. 171-183, Oxford University Press, Oxford
49. Dean, R. T., Fu, S., Stocker, R. and Davies, M. J. (1997) Biochemistry and pathology of radical-mediated protein oxidation. Biochem. J. 324, 1-18
50. Dunlop, R. A., Rodgers, K. J. and Dean, R. T. (2002) Recent developments in the intracellular degradation of oxidized proteins. Free Radic. Biol. Med. 33, 894-906
51. Heinecke, J. W. (1999) Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders. J. Lab. Clin. Med. 133, 321-325
52. Pattison, D. I. and Davies, M. J. (2001) Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds. Chem. Res. Toxicol. 14, 1453-1464
53. Heinecke, J. W., Li, W., Francis, G. A. and Goldstein, J. A. (1993) Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J. Clin. Invest. 91, 2866-2872
54. Fu, S., Wang, H., Davies, M. J. and Dean, R. T. (2000) Reaction of hypochlorous acid with tyrosine and peptidyl-tyrosyl residues gives dichlorinated and aldehydic products in addition to 3-chlorotyrosine. J. Biol. Chem. 275, 10851-10858
55. Weiss, S. J., Lampert, M. B. and Test, S. T. (1983) Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science 222, 625-628
56. Davies, M. J. and Dean, R. T. (1997) Radical-Mediated Protein Oxidation: from Chemistry to Medicine, Oxford University Press, Oxford
57. Hawkins, C. L. and Davies, M. J. (2001) Generation and propagation of radical reactions on proteins. Biochim. Biophys. Acta 1504, 196-219
58. Morin, B., Davies, M. J. and Dean, R. T. (1998) The protein oxidation product 3,4-dihydroxyphenylalanine (DOPA) mediates oxidative DNA damage. Biochem. J 330, 1059-1067
59. Pattison, D. I., Dean, R. T. and Davies, M. J. (2002) Oxidation of DNA, proteins and lipids by DOPA, protein-bound DOPA, and related catechols and catecholamines. Toxicology 177, 23-37